Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Explains How its New Incentive Program for Rare Pediatric Disease Treatments Works
RAPS.org
Wednesday, November 19, 2014 - 8:48am
tags:
FDA, pediatric, R&D
FDA Cracking Down on Attempts to Delay Entry of Generic Drugs, Data Show
RAPS.org
Wednesday, November 19, 2014 - 8:46am
tags:
FDA, generics
Painkiller marketing secrets? Check Chicago's unredacted suit against Endo, Purdue, Cephalon, et al.
Fierce Pharma Marketing
Wednesday, November 19, 2014 - 8:42am
tags:
painkillers, chicago, Endo Health Solutions, Purdue, Cephalon
J&J, Boston Scientific $5B trial to begin Thursday
Seeking Alpha
Wednesday, November 19, 2014 - 8:33am
tags:
JNJ, Boston Scientific, devices, Guidant
Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
Yahoo/Bloomberg
Wednesday, November 19, 2014 - 8:31am
tags:
Bill Gates, ebola virus, Chimerix, clinical trials
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
TheStreet.com
Wednesday, November 19, 2014 - 8:30am
tags:
Agios Pharmaceuticals, leukemia, AG-120, AML
Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln
Yahoo/Reuters
Wednesday, November 19, 2014 - 8:27am
tags:
Royalty Pharma, Vertex Pharma, cystic fibrosis
Allergan’s Price Tag Gets Even Richer
WSJ Online
Wednesday, November 19, 2014 - 8:26am
tags:
Allergan, Actavis, Valeant Pharmaceuticals, M&A
Why VIVUS (VVUS) Might Be a Diamond in the Rough
Yahoo/Zacks.com
Wednesday, November 19, 2014 - 8:24am
tags:
Vivus
Regeneron drug highly effective for those who can't take statins: study
Reuters
Tuesday, November 18, 2014 - 3:49pm
tags:
Regeneron, statins, Sanofi, alirocumab
Organovo begins selling 3D printed liver tissue
Yahoo/Gigaom
Tuesday, November 18, 2014 - 3:47pm
tags:
Organovo, 3D printing, liver
AstraZeneca’s Soriot Asks for Patience as Pfizer Return Looms
Bloomberg
Tuesday, November 18, 2014 - 3:45pm
tags:
AstraZeneca, Pfizer, Pascal Soriot
Average cost of drug R&D? Try $2.9B on for size
Fierce Biotech
Tuesday, November 18, 2014 - 11:53am
tags:
R&D
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Tuesday, November 18, 2014 - 11:51am
tags:
Clovis, GSK, non-small cell lung cancer, Mekinist, rociletinib
DaVita, Medtronic to study arrhythmia in dialysis patients
Mass Device
Tuesday, November 18, 2014 - 11:02am
tags:
DaVita, Medtronic, arrhythmia, dialysis, devices
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Fierce Pharma Marketing
Tuesday, November 18, 2014 - 11:01am
tags:
Sanofi, Lemtrada, MS, multiple sclerosis
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
TheStreet.com
Tuesday, November 18, 2014 - 10:59am
tags:
Gilead Sciences, Harvoni, Europe, hepatitis C
Novartis' Drug Could Change Course of Heart Failure for Patients
Drug Discovery and Development
Tuesday, November 18, 2014 - 10:37am
tags:
Novartis, LCZ696, heart failure
Celldex Therapeutics To Enter Talks With FDA
Seeking Alpha
Tuesday, November 18, 2014 - 10:35am
tags:
Celldex Therapeutics, FDA, GBM, rindopepimut, glioblastoma multiforme
FDA Delays Final Rule on Allowing Generic Drug Makers to Update Labels
WSJ Pharmalot
Tuesday, November 18, 2014 - 10:10am
tags:
FDA, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.